• History And Milestones
  • In 1992, Poly was established in Hainan province.

  • In 1995, Poly’s first product, Nimodipine capsule, gained Market Authorization in China.

  • After 2010, Poly was subsequently inspected by authorities of WHO, EU EMA, US FDA. The first product Ganciclovir was exported to Germany and Netherlands.

  • In 2015, the manufacturing facility in Hainan was rated as “Demonstration Factory of Intelligent Production in Pharmaceutical Industry” by Chinese government.

  • In 2017, Poly completed Initial Public Offering and was listed on Shenzhen Stock Exchange (300630.SZ) with approximate US$1.5 billion of market value (July 2018).
    A new facility in Hangzhou started its operation.

  • In 2018, the third facility laid its foundation in Anqing for high-end API with designed capacity of 300 tons.

©2017 Hainan Poly Co. Ltd All rights reserved     瓊ICP備11000362號-1
广西快乐10分开奖直播 北京体彩11选5100期走势图 福彩26选5开奖结果 互联网理财平台有哪些 黑龙江快乐十分11选五中多少钱 天津体彩彩票十一选五 股票投资收益率 江南高纤股票分析 青海十一选五几率 赌博app下载大全 大盘蓝筹股票